Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 196 AL 210

[Role of syndecan-2 in amyloid plaque formation]

Leonova EI, Galzitskaia OV.

Mol Biol (Mosk). 2015 Jan-Feb;49(1):89-98.

Neuroanatomy and pathology of sporadic Alzheimer's disease

Braak H, Del Tredici K.

Adv Anat Embryol Cell Biol. 2015;215:1-162.

Rodent models for Alzheimer's disease drug discovery

Puzzo D, Gulisano W, Palmeri A, Arancio O.

Expert Opin Drug Discov. 2015 Jul;10(7):703-11. doi: 10.1517/17460441.2015.1041913. Epub 2015 Apr 30.

Nanomedicine for the treatment of Alzheimer's disease

Gregori M, Masserini M, Mancini S.

Nanomedicine (Lond). 2015;10(7):1203-18. doi: 10.2217/nnm.14.206.

Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial

Butchart J, Brook L, Hopkins V, Teeling J, Püntener U, Culliford D, Sharples R, Sharif S, McFarlane B, Raybould R, Thomas R, Passmore P, Perry VH, Holmes C.

Neurology. 2015 May 26;84(21):2161-8. doi: 10.1212/WNL.0000000000001617. Epub 2015 May 1.

On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients

Sala Frigerio C, Lau P, Troakes C, Deramecourt V, Gele P, Van Loo P, Voet T, De Strooper B.

Alzheimers Dement. 2015 Nov;11(11):1265-76. doi: 10.1016/j.jalz.2015.02.007. Epub 2015 Apr 29.

Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease

Clark IA, Vissel B.

Br J Pharmacol. 2015 Aug;172(15):3714-27. doi: 10.1111/bph.13181. Epub 2015 Jun 29.

Preventing the spread of Alzheimer's disease neuropathology: a role for calcilytics?

Chiarini A, Gardenal E, Whitfield JF, Chakravarthy B, Armato U, Dal Pra I.

Curr Pharm Biotechnol. 2015;16(8):696-706. doi: 10.2174/1389201016666150505123813.

Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease

Daulatzai MA.

J Neural Transm (Vienna). 2015 Oct;122(10):1475-97. doi: 10.1007/s00702-015-1404-6. Epub 2015 May 6.

Outpatient treatment of sleep disorders in Alzheimer patients

Scoralick FM, Camargos EF, Freitas MP, Nóbrega OT.

Einstein (Sao Paulo). 2015 Jul-Sep;13(3):430-4. doi: 10.1590/S1679-45082015RW3021. Epub 2015 May 1.

Reduced CSF Water Influx in Alzheimer's Disease Supporting the β-Amyloid Clearance Hypothesis

Suzuki Y, Nakamura Y, Yamada K, Igarashi H, Kasuga K, Yokoyama Y, Ikeuchi T, Nishizawa M, Kwee IL, Nakada T.

PLoS One. 2015 May 6;10(5):e0123708. doi: 10.1371/journal.pone.0123708. eCollection 2015.

[Nutritional approaches to modulate oxidative stress that induce Alzheimer's disease. Nutritional approaches to prevent Alzheimer's disease]

Lara HH, Alanís-Garza EJ, Estrada Puente MF, Mureyko LL, Alarcón Torres DA, Ixtepan Turrent L.

Gac Med Mex. 2015 Mar-Apr;151(2):245-51.

T Cells-Protective or Pathogenic in Alzheimer's Disease?

McManus RM, Mills KH, Lynch MA.

J Neuroimmune Pharmacol. 2015 Dec;10(4):547-60. doi: 10.1007/s11481-015-9612-2. Epub 2015 May 10.

Is interaction of amyloid β-peptides with metals involved in cognitive activity?

Tamano H, Takeda A.

Metallomics. 2015 Aug;7(8):1205-12. doi: 10.1039/c5mt00076a.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias